Late Ambulatory DMD News, Researches, Clinical Trials and Articles

Together, we will keep fighting for better treatments and access for everyone with Duchenne.

Powered by Hostinger

Press Releases September 11, 2026 0

Exegenesis Bio and Modalis Therapeutics Corporation have announced a...

Research September 10, 2026 0

Tevard’s suppressor tRNA therapy could offer a new way...

Press Releases September 9, 2026 0

Satellos Bioscience has announced that its investigational Duchenne muscular...

Approved Therapies August 21, 2026 0

Duchenne muscular dystrophy (DMD) is a genetic condition that...

Editorials April 10, 2026 0

The landscape of potential new gene therapies for Duchenne...

Editorials April 6, 2026 0

The duchenne muscular dystrophy treatment cost has become one...

Late Ambulatory DMD